Food, Health & Wellness News
-
Scythian Biosciences Corp. Announces Approval for Listing on the Nasdaq Capital Markets under Symbol “SCYB” and Ringing of the Nasdaq Closing Bell
February 14, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to…
-
Scythian Biosciences Announces Closing of $28.7 Million Financing with Aphria Inc. as Lead Investor
February 13, 2018 (Source) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to…
-
Global Cannabis Partners with Global Marketing Firm BuzzHunter for its Upcoming Citizen Green ICO
February 8, 2018 (Source) — Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE: 2FA, OTCQB: FUAPF), a…
-
BlueOcean NutraSciences Inc. Announces the Issuance of Shares for Debt
February 7, 2018 (Source) — BlueOcean NutraSciences Inc. (“BlueOcean” or the “Company”) (TSX-V: BOC) announces that in accordance with…
-
BlueOcean NutraSciences Grants Stock Options
January 25, 2018 (Source) — BlueOcean NutraSciences Inc. (“BlueOcean” or the “Company”) (TSX-V: BOC) announces that the Board of Directors…
-
BlueOcean NutraSciences announces Shares for Debt Transaction
January 25, 2018 (Source) — BlueOcean NutraSciences Inc. (“BlueOcean” or the “Company”) (TSX-V: BOC) BlueOcean NutraSciences announces that BlueOcean and…
-
BlueOcean NutraSciences Inc. Updates Changes to Management and Announces Shares for Services Agreement
January 22, 2018 (Source) — BlueOcean NutraSciences Inc. (TSXV:BOC) (“BlueOcean” or the “Company”) is pleased to update its press release dated November…
-
Global Cannabis Announces World Leading Experts to Advisory Board for Pending ICO Launch
January 18, 2018 (Source) — Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE:2FA, OTCQB: FUAPF), a leading…
-
Global Cannabis Empowers Canadian Med Canna Patients with Launch of Prescriptii App
January 18, 2018 (Source) — Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE: APP, FSE:2FA, OTCQB: FUAPF), a leading…
-
Scythian Biosciences Corp. Announces Increase to Bought Deal Financing With Serruya Private Equity and the Delavaco Group as Other Strategic Investors
January 17, 2018 (Source) — Scythian Biosciences Corp. (TSX VENTURE:SCYB) (the “Company”) is pleased to announce today that, due…
